The Australia-based drug manufacturer is working to release Pixclara, a PET contrast agent for diagnosing glioma, a rare form of brain cancer. 

The technique has proven effective in adults, but until recently there has been a lack of data on its use among children.

Rising imaging volumes have led to an uptick in the unearthing of unexpected breast lesions, with a corresponding jump in follow-up examinations.

“The explanation here is simple. Ultrasound gives you more information, and more concrete information, about what’s going on,” authors of a new JAMA study say.

“FDA clearance comes at the perfect time, with guidelines being adopted clinically for cardiac CT and with positive reimbursement driving procedure growth," says Jean-Luc Procaccini, CEO, molecular imaging and CT.

The study, which will be funded by a $2.3 million grant from the U.S. Department of Defense, will harness the power of advanced MRI technology to visualize the brain in a way that has not previously been possible.  

Pei-Ni Jone, MD, FASE, director, echocardiography laboratory, Lurie Children’s Hospital Heart Center, member of the American Society of Echocardiography (ASE) Board, explains how 3D echo is being used to better plan, guide and follow up in congenital cardiac surgery.

Jaime Warren, EdD, FACC, vice president of care transformation at MedAxiom, an ACC company, explains what is needed to address staffing shortages created by a 94% increase in cardiac CT volumes over the past 5 years.